These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21513712)

  • 21. Nucleic acid recognizing Toll-like receptors and autoimmunity.
    von Landenberg P; Bauer S
    Curr Opin Immunol; 2007 Dec; 19(6):606-10. PubMed ID: 18060756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement and Toll-like receptors: key regulators of adaptive immune responses.
    Hawlisch H; Köhl J
    Mol Immunol; 2006 Jan; 43(1-2):13-21. PubMed ID: 16019071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammasomes and rheumatic diseases: evolving concepts.
    Sidiropoulos PI; Goulielmos G; Voloudakis GK; Petraki E; Boumpas DT
    Ann Rheum Dis; 2008 Oct; 67(10):1382-9. PubMed ID: 17921182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pattern recognition receptors as potential therapeutic targets in inflammatory rheumatic disease.
    Mullen LM; Chamberlain G; Sacre S
    Arthritis Res Ther; 2015 May; 17(1):122. PubMed ID: 25975607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The orchestra of Toll-like receptors and their potential role in frequently occurring rheumatic conditions.
    Roelofs MF; Abdollahi-Roodsaz S; Joosten LA; van den Berg WB; Radstake TR
    Arthritis Rheum; 2008 Feb; 58(2):338-48. PubMed ID: 18240239
    [No Abstract]   [Full Text] [Related]  

  • 26. New developments in Toll-like receptor targeted therapeutics.
    Connolly DJ; O'Neill LA
    Curr Opin Pharmacol; 2012 Aug; 12(4):510-8. PubMed ID: 22748800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
    Fukata M; Vamadevan AS; Abreu MT
    Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primer: inflammasomes and interleukin 1beta in inflammatory disorders.
    Church LD; Cook GP; McDermott MF
    Nat Clin Pract Rheumatol; 2008 Jan; 4(1):34-42. PubMed ID: 18172447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toll-like receptor 9 signaling protects against murine lupus.
    Wu X; Peng SL
    Arthritis Rheum; 2006 Jan; 54(1):336-42. PubMed ID: 16385525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll-like receptors in autoimmunity.
    Fischer M; Ehlers M
    Ann N Y Acad Sci; 2008 Nov; 1143():21-34. PubMed ID: 19076342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptors in inflammation, infection and cancer.
    Chen K; Huang J; Gong W; Iribarren P; Dunlop NM; Wang JM
    Int Immunopharmacol; 2007 Oct; 7(10):1271-85. PubMed ID: 17673142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toll-like receptor signaling and atherosclerosis.
    Michelsen KS; Arditi M
    Curr Opin Hematol; 2006 May; 13(3):163-8. PubMed ID: 16567960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation.
    Hu X; Chen J; Wang L; Ivashkiv LB
    J Leukoc Biol; 2007 Aug; 82(2):237-43. PubMed ID: 17502339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drugs targeting Toll-like receptors.
    Krishnan J; Lee G; Choi S
    Arch Pharm Res; 2009 Nov; 32(11):1485-502. PubMed ID: 20091261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptors pathways implication in common autoimmune diseases and therapeutic perspectives.
    Alexoudi I; Kapsimali V; Vaiopoulos A; Kanakis M; Vaiopoulos G
    G Ital Dermatol Venereol; 2015 Apr; 150(2):255-60. PubMed ID: 25876147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toll-like receptors, endogenous ligands, and systemic autoimmune disease.
    Rifkin IR; Leadbetter EA; Busconi L; Viglianti G; Marshak-Rothstein A
    Immunol Rev; 2005 Apr; 204():27-42. PubMed ID: 15790348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of toll-like receptors in solid organ transplantation.
    Obhrai J; Goldstein DR
    Transplantation; 2006 Feb; 81(4):497-502. PubMed ID: 16495791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease.
    Sobek V; Birkner N; Falk I; Würch A; Kirschning CJ; Wagner H; Wallich R; Lamers MC; Simon MM
    Arthritis Res Ther; 2004; 6(5):R433-46. PubMed ID: 15380043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene/environment interactions in the pathogenesis of autoimmunity: new insights on the role of Toll-like receptors.
    Gianchecchi E; Fierabracci A
    Autoimmun Rev; 2015 Nov; 14(11):971-83. PubMed ID: 26184547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists.
    Kanzler H; Barrat FJ; Hessel EM; Coffman RL
    Nat Med; 2007 May; 13(5):552-9. PubMed ID: 17479101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.